Molecular Partners (MOLN) News Today $3.72 +0.00 (+0.03%) Closing price 03:55 PM EasternExtended Trading$3.75 +0.03 (+0.75%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MOLN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period JPMorgan Chase & Co. Issues Pessimistic Forecast for Molecular Partners (NASDAQ:MOLN) Stock PriceSeptember 5, 2025 | marketbeat.comJPMorgan Chase & Co. Has Lowered Expectations for Molecular Partners (NASDAQ:MOLN) Stock PriceSeptember 5, 2025 | americanbankingnews.comLeerink Partnrs Issues Optimistic Estimate for MOLN EarningsAugust 30, 2025 | marketbeat.comQ3 EPS Forecast for Molecular Partners Lifted by AnalystAugust 30, 2025 | americanbankingnews.comMolecular Partners (NASDAQ:MOLN) Issues Quarterly Earnings ResultsAugust 27, 2025 | marketbeat.comMolecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025August 25, 2025 | globenewswire.comMolecular Partners appoints Martin Steegmaier as chief scientific officerAugust 21, 2025 | msn.comMolecular Partners (MOLN) Expected to Announce Earnings on MondayAugust 19, 2025 | marketbeat.comMolecular Partners (NASDAQ:MOLN) Stock Price Down 0.7% - Should You Sell?August 16, 2025 | marketbeat.comMolecular Partners AG ADR MOLN (U.S.: Nasdaq) - The Wall Street JournalAugust 5, 2025 | wsj.comMolecular Partners (NASDAQ:MOLN) Stock Price Up 4.3% - Here's WhyJuly 24, 2025 | marketbeat.comMolecular Partners AG News (MOLN) - Investing.comJuly 2, 2025 | investing.comMolecular Partners (NASDAQ:MOLN) Stock Price Down 3.4% - Should You Sell?July 2, 2025 | marketbeat.comMolecular Partners AG (MOLN) - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comMolecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025 - MorningstarJune 24, 2025 | morningstar.comMMolecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025June 22, 2025 | globenewswire.comMolecular Partners Reports Positive Phase 1/2a Data for MP0533 in Relapsed/Refractory AML at EHA CongressJune 12, 2025 | nasdaq.comMolecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025June 11, 2025 | uk.finance.yahoo.comMolecular Partners to cut jobs, cash reach now anticipated to extend into 2028June 10, 2025 | msn.comMolecular Partners (NASDAQ:MOLN) Shares Up 2.2% - Time to Buy?June 10, 2025 | marketbeat.comMolecular Partners Announces Planned Operational Efficiencies and Extension of Cash RunwayJune 10, 2025 | globenewswire.comBrokers Offer Predictions for MOLN Q2 EarningsMay 20, 2025 | marketbeat.comSuvretta Capital Management LLC Has $10.55 Million Stake in Molecular Partners AG (NASDAQ:MOLN)May 19, 2025 | marketbeat.comMolecular Partners to Present at Upcoming Investor ConferencesMay 19, 2025 | globenewswire.comMolecular Partners Reports Financial Results and Highlights from Q1 2025May 15, 2025 | finance.yahoo.comBVF Inc. IL Acquires 910,747 Shares of Molecular Partners AG (NASDAQ:MOLN)May 6, 2025 | marketbeat.comMolecular Partners presents new data on Radio-DARPin, Switch-DARPin programsApril 26, 2025 | markets.businessinsider.comMolecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025April 25, 2025 | globenewswire.comMolecular Partners (NASDAQ:MOLN) Trading 2.9% Higher - Here's What HappenedApril 25, 2025 | marketbeat.comMolecular Partners Announces all Board Proposals Approved at Annual General MeetingApril 16, 2025 | globenewswire.comDendi and Molecular Lab Partners Announce Strategic Partnership to Empower Labs NationwideApril 15, 2025 | tmcnet.comHedge funds owners may take dramatic actions as Molecular Partners AG's (VTX:MOLN) recent 15% drop adds to one-year lossesApril 6, 2025 | finance.yahoo.comMolecular Partners (NASDAQ:MOLN) Shares Down 0.5% - What's Next?April 3, 2025 | marketbeat.comMolecular Partners to hold three poster presentations at AACR 2025March 25, 2025 | globenewswire.comMolecular Partners Publishes Invitation to Annual General Meeting 2025March 25, 2025 | globenewswire.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Molecular Partners (MOLN), United Therapeutics (UTHR) and Universal Health (UHS)March 17, 2025 | markets.businessinsider.comMolecular Partners (MOLN) Initiated with a Buy at LifeSci CapitalMarch 15, 2025 | markets.businessinsider.comMolecular Partners (NASDAQ:MOLN) Coverage Initiated by Analysts at Lifesci CapitalMarch 12, 2025 | marketbeat.comLifeSci Capital Initiates Coverage of Molecular Partners AG - Depositary Receipt () (MOLN) with Outperform RecommendationMarch 12, 2025 | msn.comMolecular Partners initiated with an Outperform at LifeSci CapitalMarch 11, 2025 | markets.businessinsider.comMolecular Partners AG (NASDAQ:MOLN) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | msn.comFY2024 Earnings Estimate for MOLN Issued By Leerink PartnrsMarch 10, 2025 | marketbeat.comMolecular Partners Full Year 2024 Earnings: CHF1.59 loss per share (vs CHF1.89 loss in FY 2023)March 9, 2025 | finance.yahoo.comMolecular Partners AG (MLLCF) (FY 2024) Earnings Call Highlights: Strategic Shifts and ...March 8, 2025 | gurufocus.comFull Year 2024 Molecular Partners AG Earnings Call TranscriptMarch 7, 2025 | gurufocus.comMolecular Partners AG: Strategic Advances and Financial OverviewMarch 7, 2025 | tipranks.comMolecular Partners (NASDAQ:MOLN) Releases Earnings Results, Beats Estimates By $0.11 EPSMarch 7, 2025 | marketbeat.comMolecular Partners AG (MOLN) Q4 2024 Earnings Call TranscriptMarch 7, 2025 | seekingalpha.comMolecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024March 6, 2025 | globenewswire.comMolecular Partners (NASDAQ:MOLN) Trading 0.3% Higher - What's Next?March 1, 2025 | marketbeat.com Get Molecular Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for MOLN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MOLN Media Mentions By Week MOLN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MOLN News Sentiment▼-0.750.84▲Average Medical News Sentiment MOLN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MOLN Articles This Week▼21▲MOLN Articles Average Week Get the Latest News and Ratings for MOLN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Molecular Partners and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Tourmaline Bio News Today Siga Technologies News Today Palvella Therapeutics News Today Inventiva News Today MeiraGTx News Today Opthea News Today Xencor News Today AnaptysBio News Today Arvinas News Today Savara News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MOLN) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemTucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...True Market Insiders | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
